The start of the new year is typically a time when people make big changes around health—and drug companies are no exception.
As of Jan. 1, more than 250 branded drugs from pharmaceutical giants including Bristol Myers Squibb, Sanofi-Pasteur, Merck, Pfizer, and more will see price hikes in the U.S., according to data analysis conducted by health care research firm 3 Axis Advisors.
